ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,403Medicare Part D Prescriptions Filled, Including Refills

Rank: 535 out of 2061

$581K Total Retail Price of All Prescriptions

Rank: 519 out of 2061

346 Patients Receiving at Least One Drug in Part D
68%Patients 65 Years and Older
60% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Ohio
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 346 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

15% of this provider’s 346 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 5,780 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Ohio
LISINOPRIL 385 256 1 2
SIMVASTATIN 300 172 2 1
OMEPRAZOLE 283 194 3 5
LEVOTHYROXINE SODIUM 269 197 4 3
HYDROCODONE-ACETAMINOPHEN 223 81 S3 5 10
METFORMIN HCL 212 105 6 9
METOPROLOL TARTRATE 210 133 7 7
AMLODIPINE BESYLATE 206 195 8 4
HYDROCHLOROTHIAZIDE 150 97 9 12
CARVEDILOL 126 108 10 22
LOVASTATIN 124 88 11 35
FUROSEMIDE 123 118 12 6
GABAPENTIN 120 60 13 15
POTASSIUM CHLORIDE 117 91 14 16
ATORVASTATIN CALCIUM 107 84 15 8
WARFARIN SODIUM 106 82 16 11
FLUTICASONE PROPIONATE 102 54 17 43
GLIMEPIRIDE 97 64 18 33
CLOPIDOGREL 95 71 19 29
PROAIR HFA 91 26 20 40
PRAVASTATIN SODIUM 90 62 21 14
OXYCODONE-ACETAMINOPHEN 89 31 S2 22 36
ALENDRONATE SODIUM 89 85 22 25
TRAMADOL HCL 87 72 24 18
ATENOLOL 85 52 25 13
ZOLPIDEM TARTRATE 82 43 26 23
LOSARTAN POTASSIUM 81 52 27 17
AZITHROMYCIN 78 51 28 34
CITALOPRAM HBR 77 50 29 20
NAMENDA 75 68 30 37
PREDNISONE 72 52 31 32
TRIAMTERENE-HCTZ 72 49 31 38
SPIRIVA 71 28 33 63
PLAVIX 70 44 34 49
ALLOPURINOL 68 32 35 28
NEXIUM 67 40 36 26
QUETIAPINE FUMARATE 65 46 37 72
FINASTERIDE 64 52 38 86
CLONIDINE HCL 62 23 39 52
MELOXICAM 62 37 39 44
SERTRALINE HCL 61 40 41 21
TIZANIDINE HCL 61 0 41 137
POLYETHYLENE GLYCOL 3350 61 0 41 64
FLUOXETINE HCL 61 14 41 73
TOPIRAMATE 59 0 45 190
CELEBREX 56 21 46 91
DONEPEZIL HCL 55 55 47 24
RANITIDINE HCL 53 37 48 53
TAMSULOSIN HCL 53 30 48 30
LIPITOR 52 29 50 70
IBUPROFEN 52 0 50 90
MIRTAZAPINE 50 41 52 46
SPIRONOLACTONE 50 28 52 62
MORPHINE SULFATE ER 50 0 S2 52 166
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 14, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.